Biblio

Author Title [ Type(Desc)] Year
Filters: Author is Sanvito, Francesca  [Clear All Filters]
Journal Article
Colantuoni M, Hernández RJofra, Pettinato E, Basso-Ricci L, Magnani L, Andolfi G, Rigamonti C, Finardi A, Romeo V, Soldi M, et al. Constitutive IL-1RA production by modified immune cells protects against IL-1-mediated inflammatory disorders. Sci Transl Med. 2023;15(698):eade3856.
Ruggiero E, Carnevale E, Prodeus A, Magnani ZIrene, Camisa B, Merelli I, Politano C, Stasi L, Potenza A, Cianciotti BClaudia, et al. CRISPR-based gene disruption and integration of high-avidity, WT1-specific T cell receptors improve antitumor T cell function. Sci Transl Med. 2022;14(631):eabg8027.
Greco B, Malacarne V, De Girardi F, Scotti GMaria, Manfredi F, Angelino E, Sirini C, Camisa B, Falcone L, Moresco MAngiola, et al. Disrupting N-glycan expression on tumor cells boosts chimeric antigen receptor T cell efficacy against solid malignancies. Sci Transl Med. 2022;14(628):eabg3072.
Meneghini V, Frati G, Sala D, De Cicco S, Luciani M, Cavazzin C, Paulis M, Mentzen W, Morena F, Giannelli S, et al. Generation of Human Induced Pluripotent Stem Cell-Derived Bona Fide Neural Stem Cells for Ex Vivo Gene Therapy of Metachromatic Leukodystrophy. Stem Cells Transl Med. 2016.
Hernández RJofra, Calabria A, Sanvito F, De Mattia F, Farinelli G, Scala S, Visigalli I, Carriglio N, De Simone M, Vezzoli M, et al. Hematopoietic Tumors in a Mouse Model of X-linked Chronic Granulomatous Disease after Lentiviral Vector-Mediated Gene Therapy. Mol Ther. 2020.
Mangiameli E, Cecchele A, Morena F, Sanvito F, Matafora V, Cattaneo A, Volpe LDella, Gnani D, Paulis M, Susani L, et al. Human iPSC-based neurodevelopmental models of globoid cell leukodystrophy uncover patient- and cell type-specific disease phenotypes. Stem Cell Reports. 2021.
Asperti C, Canarutto D, Porcellini S, Sanvito F, Cecere F, Vavassori V, Ferrari S, Rovelli E, Albano L, Jacob A, et al. Scalable GMP-compliant gene correction of CD4+ T cells with IDLV template functionally validated and . Mol Ther Methods Clin Dev. 2023;30:546-557.